CN Patent
CN104623684B — 一种恩格列净甘露醇组合物的制备方法
Assigned to Zhejiang Huahai Pharmaceutical Co Ltd · Expires 2020-12-25 · 5y expired
What this patent protects
本发明提供了一种恩格列净甘露醇组合物的制备方法,将恩格列净与甘露醇混合后经热熔制粒,再与其他药学上可接受的载体混合后制成口服固体制剂。通过本发明方法制备的恩格列净甘露醇组合物质量稳定可控,溶出迅速。
USPTO Abstract
本发明提供了一种恩格列净甘露醇组合物的制备方法,将恩格列净与甘露醇混合后经热熔制粒,再与其他药学上可接受的载体混合后制成口服固体制剂。通过本发明方法制备的恩格列净甘露醇组合物质量稳定可控,溶出迅速。
Drugs covered by this patent
- Jardiance (empagliflozin) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.